AkzoNobel’s Purate business specializes in global antimicrobial water treatment technology.
Ecolab Inc. has reached an agreement to acquire AkzoNobel’s Purate business, which specializes in global antimicrobial water treatment technology. With 2012 revenue of approximately $23 million, the Purate business provides patented, proprietary chlorine dioxide programs for use in a wide array of water treatment applications. Completion of the transaction is subject to customary regulatory clearances and other standard closing conditions.
RELATED: Ecolab acquires Champion Technologies
"Chlorine dioxide is recognized as an excellent antimicrobial agent to control biologic growth primarily in cooling towers and a wide variety of other industrial water treatment applications," said Timothy Mulhere, Ecolab executive vice president and president, Global Water and Process Services. "Purate’s patented technologies complement our offerings globally."
Ecolab 3D TRASAR technology is said to combine chemistry, remote services and sophisticated monitoring and controls to improve a range of industrial operations to help customers reduce water use, improve energy efficiency and lower total cost of operations.
RELATED: Ecolab closes on OR Solutions purchase
With more than one million customer locations, Ecolab provides water, hygiene and energy technologies and services, with 2012 sales of $12 billion and 41,000 employees for customers in the food, healthcare, energy, hospitality, commercial laundry and industrial markets in more than 170 countries around the world.